Differential IL-12 responsiveness of T cells but not of NK cells from tumor-bearing mice in IL-12-responsive versus -unresponsive tumor models

被引:19
作者
Iwasaki, M [1 ]
Yu, WG [1 ]
Uekusa, Y [1 ]
Nakajima, C [1 ]
Yang, YF [1 ]
Gao, P [1 ]
Wijesuriya, R [1 ]
Fujiwara, H [1 ]
Hamaoka, T [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Ctr Biomed Res, Dept Oncol, Suita, Osaka 5650871, Japan
关键词
IL-12; NK cells; tumor models;
D O I
10.1093/intimm/12.5.701
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
While IL-12 administration induces tumor regression through stimulating T cells in tumor-bearing mice, this IL-12 effect is observed in some but not all tumor models. The present study aimed to compare IL-12 responsiveness of T cells from tumor-bearing mice in IL-12-responsive (CSA1M and OV-HM) and -unresponsive (Meth A) tumor models, Tumor regression in IL-12-responsive tumor models required the participation of T cells, but not of NK1.1(+) cells. Because a NK1.1(+) cell population was the major producer of IFN-gamma, comparable levels of IFN-gamma production were induced in IL-12-responsive and -unresponsive tumor-bearing mice. This indicates that the amount of IFN-gamma produced in tumor-bearing individuals does not correlate with the anti-tumor efficacy of IL-12, In contrast, IL-12 responsiveness of T cells differed between the responsive and unresponsive models: purified T cells from CSA1M/OV-HM-bearing or Meth A-bearing mice exhibited high or low IL-12 responsiveness respectively, when evaluated by the amounts of IFN-gamma produced in response to IL-12, T cells from CSA1M- or OV-HM-bearing but not from Meth A-bearing mice exhibited enhanced levels of mRNA for the IL-12 receptor (IL-12R), These results indicate that a fundamental difference exists in IL-12 responsiveness of T cells between IL-12-responsive and -unresponsive tumor models, and that such a difference is associated with the expression of IL-12R on T cells.
引用
收藏
页码:701 / 709
页数:9
相关论文
共 36 条
[1]   TGF-BETA INDUCES BIMODAL PROLIFERATION OF CONNECTIVE-TISSUE CELLS VIA COMPLEX CONTROL OF AN AUTOCRINE PDGF LOOP [J].
BATTEGAY, EJ ;
RAINES, EW ;
SEIFERT, RA ;
BOWENPOPE, DF ;
ROSS, R .
CELL, 1990, 63 (03) :515-524
[2]  
BRUNDA MJ, 1994, J LEUKOCYTE BIOL, V55, P280
[3]   ROLE OF INTERFERON-GAMMA IN MEDIATING THE ANTITUMOR EFFICACY OF INTERLEUKIN-12 [J].
BRUNDA, MJ ;
LUISTRO, L ;
HENDRZAK, JA ;
FOUNTOULAKIS, M ;
GAROTTA, G ;
GATELY, MK .
JOURNAL OF IMMUNOTHERAPY, 1995, 17 (02) :71-77
[4]   ANTITUMOR AND ANTIMETASTATIC ACTIVITY OF INTERLEUKIN-12 AGAINST MURINE TUMORS [J].
BRUNDA, MJ ;
LUISTRO, L ;
WARRIER, RR ;
WRIGHT, RB ;
HUBBARD, BR ;
MURPHY, M ;
WOLF, SF ;
GATELY, MK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (04) :1223-1230
[5]  
CENTRELLA M, 1987, J BIOL CHEM, V262, P2869
[6]   INDUCTION OF INTERFERON-GAMMA PRODUCTION BY NATURAL-KILLER-CELL STIMULATORY FACTOR - CHARACTERIZATION OF THE RESPONDER CELLS AND SYNERGY WITH OTHER INDUCERS [J].
CHAN, SH ;
PERUSSIA, B ;
GUPTA, JW ;
KOBAYASHI, M ;
POSPISIL, M ;
YOUNG, HW ;
WOLF, SF ;
YOUNG, D ;
CLARK, SC ;
TRINCHIERI, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :869-879
[7]  
CHUA AO, 1995, J IMMUNOL, V155, P4286
[8]  
CUL J, 1997, SCIENCE, V278, P1623
[9]  
DESAI BB, 1992, J IMMUNOL, V148, P3125
[10]   Cellular and molecular mechanisms underlying IL-12-induced tumor regression [J].
Fujiwara, H ;
Clark, SC ;
Hamaoka, T .
INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 :294-309